ASCEND BY NTHRYS
Research Abroad Products

Genetics Project Topics

Browse all focused areas across all project categories under this field.

Showing 1393–1404 of 2020 project topics
Barriers to Genetic Testing Access Research
Identifying social, economic, and systemic barriers to genetic testing access and developing interventions for reducing health disparities in genetics.
Genomic Medicine Implementation Research Click to view more details →
Cost-Effectiveness of Genomic Screening Programs
Conducting health economic analyses of population genomic screening programs for hereditary cancer and other conditions for informing policy decisions.
Genomic Medicine Implementation Research Click to view more details →
Clinical Decision Support Systems for Variant Interpretation
SaaS platforms that automate the classification and clinical significance assessment of genetic variants using machine learning algorithms and curated databases. These tools reduce interpretation time by 70% and enable laboratories to process higher sample volumes while maintaining accuracy and compliance with regulatory standards.
Genomic Medicine Implementation Research Click to view more details →
Pharmacogenomics Testing Integration into Pharmacy Workflows
Commercial software solutions that embed pharmacogenomic testing recommendations directly into pharmacy management systems and electronic prescription platforms. This creates new revenue streams through testing services while reducing adverse drug events and improving medication adherence metrics for healthcare providers.
Genomic Medicine Implementation Research Click to view more details →
Genetic Data Privacy and Compliance Management Solutions
Enterprise-grade platforms designed to securely manage sensitive genomic data while ensuring HIPAA, GDPR, and FDA compliance for clinical and research settings. These tools generate recurring SaaS revenue through subscription models while protecting organizations from costly regulatory violations and data breach liabilities.
Genomic Medicine Implementation Research Click to view more details →
Direct-to-Consumer Genomic Report Commercialization Platforms
White-label software solutions enabling healthcare companies and retailers to deliver personalized genomic reports directly to consumers with actionable health recommendations. These platforms monetize through per-test fees, wellness program partnerships, and longitudinal health monitoring subscriptions that drive customer lifetime value.
Genomic Medicine Implementation Research Click to view more details →
Polygenic Risk Score Development and Clinical Deployment Tools
Advanced computational platforms that develop, validate, and integrate polygenic risk scores for common diseases into clinical workflows and patient risk stratification systems. These solutions create competitive advantages for laboratories and enable precision prevention programs that generate revenue through risk-based screening and early intervention services.
Genomic Medicine Implementation Research Click to view more details →
Genomic Data Marketplace and Licensing Technology Infrastructure
B2B platforms that facilitate secure aggregation, standardization, and commercialization of de-identified genomic datasets for research and pharmaceutical development. These marketplaces generate revenue through data licensing fees, analytics services, and partnership commissions while creating valuable data assets for AI model training and drug discovery.
Genomic Medicine Implementation Research Click to view more details →
Hereditary Leiomyomatosis and RCC FH Testing
Characterizing fumarate hydratase gene variants causing hereditary leiomyomatosis and renal cell carcinoma for surveillance and surgical planning.
Genetic Basis of Connective Tissue Tumors Click to view more details →
SDHA-D Paraganglioma Pheochromocytoma Genetics
Testing SDHx gene complex variants in paraganglioma and pheochromocytoma for molecular subtype diagnosis and metastasis risk stratification.
Genetic Basis of Connective Tissue Tumors Click to view more details →
NF1 Associated GIST and Malignancy Risk
Characterizing NF1 variant spectrum and investigating risk factors for GIST, malignant peripheral nerve sheath tumor, and other NF1-associated malignancies.
Genetic Basis of Connective Tissue Tumors Click to view more details →
Hereditary GIST SDHA and KIT Germline Testing
Developing testing algorithms for detecting germline KIT, PDGFRA, and SDHA mutations in apparently sporadic GIST patients with suspicious features.
Genetic Basis of Connective Tissue Tumors Click to view more details →